Porges Sclerotherapy Needles
by Porges Corp.
510(k) K896424
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK896424 | Date26 Jan 1990 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- FBK
- Device Class
- Class II
- Regulation
- 21 CFR Part 876.1500
- Advisory Committee
- Gastroenterology, Urology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 1 Oct 2026
The Porges Sclerotherapy Needles are classified as Endoscopic Injection Needles, designed for use in gastroenterology and urology procedures. These needles are intended for the injection of sclerosing agents, typically used to treat vascular malformations, hemorrhoids, or varicose veins by inducing fibrosis and occlusion of targeted vessels. Their precise design facilitates controlled delivery of therapeutic substances during endoscopic interventions.
These needles are supplied as single-use, sterile devices, adhering to regulatory standards for endoscopic instruments. They are categorized under FDA product code FBK and have received a 510(k) clearance (K896424) under the Special Controls for Class II devices. No additional context on MRI safety, reusable applications, or specific storage conditions is provided in the available data. The device is intended for professional medical use in controlled clinical settings.
Other devices from Porges Corp.
Questions
AI-generated answers, 1 Oct 2026
What are the Porges Sclerotherapy Needles used for?
These needles are designed specifically for endoscopic procedures in gastroenterology and urology. They deliver sclerosing agents to induce fibrosis and occlusion of targeted blood vessels, commonly used to treat vascular malformations, hemorrhoids, or varicose veins. Their precise design ensures controlled injection during minimally invasive interventions.
Are the Porges Sclerotherapy Needles single-use or reusable?
The Porges Sclerotherapy Needles are supplied as single-use devices. This ensures sterility and safety for each procedure, adhering to regulatory standards for endoscopic instruments. Reuse is not recommended or supported by the manufacturer.
What regulatory clearance does the Porges Sclerotherapy Needles hold?
The Porges Sclerotherapy Needles have received FDA 510(k) clearance under the product code FBK, classified as a Class II device. The clearance (K896424) was granted in 1990, affirming their substantial equivalence to a predicate device under the Special Controls for Class II devices.
How are the Porges Sclerotherapy Needles supplied?
The needles are supplied as sterile, single-use devices. While specific packaging details are not provided, they are intended for professional medical use in controlled clinical settings. Sterility is maintained to ensure safe and effective use in endoscopic procedures.
Are there different sizes or models available for the Porges Sclerotherapy Needles?
The provided data does not specify distinct sizes or models beyond the general classification as endoscopic injection needles. However, the device is categorized under FDA product code FBK, which typically includes a range of needle gauges or lengths tailored for various endoscopic applications. For exact specifications, consult the manufacturer’s documentation.